Literature DB >> 7633410

Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome.

M L Bondeson1, N Dahl, H Malmgren, W J Kleijer, T Tönnesen, B M Carlberg, U Pettersson.   

Abstract

We have recently described the identification of a second IDS locus (IDS-2) located within 90 kb telomeric of the IDS gene (Bondeson et al. submitted). Here, we show that this region is involved in a recombination event with the IDS gene in about 13% of patients with the Hunter syndrome. Analysis of the resulting rearrangement at the molecular level showed that these patients have suffered a recombination event that results in a disruption of the IDS gene in intron 7 with an inversion of the intervening DNA. Interestingly, all of the six cases with a similar type of rearrangement showed recombination between intron 7 of the IDS gene and sequences close to exon 3 at the IDS-2 locus implying that these regions are hot spots for recombination. Analysis by nucleotide sequencing showed that the inversion is caused by recombination between homologous sequences present in the IDS gene and the IDS-2 locus. No detectable deletions or insertions were observed as a result of the recombination event. The results in this study have practical implications for diagnosis of the Hunter syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633410     DOI: 10.1093/hmg/4.4.615

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  42 in total

1.  Accommodating chromosome inversions in linkage analysis.

Authors:  Gary K Chen; Erin Slaten; Roel A Ophoff; Kenneth Lange
Journal:  Am J Hum Genet       Date:  2006-06-06       Impact factor: 11.025

2.  Inversion polymorphisms and non-contiguous terminal deletions: the cause and the (unpredicted) effect of our genome architecture.

Authors:  R Ciccone; T Mattina; R Giorda; M C Bonaglia; M Rocchi; T Pramparo; O Zuffardi
Journal:  J Med Genet       Date:  2006-05       Impact factor: 6.318

3.  The same molecular mechanism at the maternal meiosis I produces mono- and dicentric 8p duplications.

Authors:  G Floridia; M Piantanida; A Minelli; C Dellavecchia; C Bonaglia; E Rossi; G Gimelli; G Croci; F Franchi; S Gilgenkrantz; P Grammatico; L Dalprá; S Wood; C Danesino; O Zuffardi
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

4.  Germline and somatic mosaicism in a female carrier of Hunter disease.

Authors:  R Froissart; I Maire; V Bonnet; T Levade; D Bozon
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 5.  CRISPR-Cas-mediated chromosome engineering for crop improvement and synthetic biology.

Authors:  Michelle Rönspies; Annika Dorn; Patrick Schindele; Holger Puchta
Journal:  Nat Plants       Date:  2021-05-06       Impact factor: 15.793

6.  Predicting Local Inversions Using Rectangle Clustering and Representative Rectangle Prediction.

Authors:  Shenglong Zhu; Scott J Emrich; Danny Z Chen
Journal:  IEEE Trans Nanobioscience       Date:  2019-06-05       Impact factor: 2.935

7.  Deep Genotyping of the IDS Gene in Colombian Patients with Hunter Syndrome.

Authors:  Johanna Galvis; Jannet González; Alfredo Uribe; Harvy Velasco
Journal:  JIMD Rep       Date:  2015-02-15

Review 8.  Mouse chromosome engineering for modeling human disease.

Authors:  Louise van der Weyden; Allan Bradley
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

9.  Inverted low-copy repeats and genome instability--a genome-wide analysis.

Authors:  Piotr Dittwald; Tomasz Gambin; Claudia Gonzaga-Jauregui; Claudia M B Carvalho; James R Lupski; Paweł Stankiewicz; Anna Gambin
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

10.  Nucleotide, cytogenetic and expression impact of the human chromosome 8p23.1 inversion polymorphism.

Authors:  Nina Bosch; Marta Morell; Immaculada Ponsa; Josep Maria Mercader; Lluís Armengol; Xavier Estivill
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.